Ricordi C, Murase N, Rastellini C, Behboo R, Demetris A J, Starzl T E
Transplantation Institute, University of Pittsburgh Medical Center, PA, USA.
Cell Transplant. 1996 Jan-Feb;5(1):53-5. doi: 10.1177/096368979600500110.
We have tested the effect of donor bone marrow cell (DBMC) infusion on the survival of pancreatic islet allografts in the rat, without the use of cytoablative recipient conditioning. Lewis and diabetic Brown Norway rats were used as donors and recipients, respectively. Donor islets were placed beneath the left renal capsule. Infusion of DBMC and temporary immunosuppression followed by delayed islet transplantation resulted in indefinite survival of all islet grafts (MST > 180 days). Control animals demonstrated recurrent hyperglycemia (islet allografts rejection). Donor bone marrow derived cells were detected in the spleen and cervical lymph nodes of BN recipients of LEW bone marrow but not in the recipients of islet transplants alone. Second set full thickness skin grafts were performed in normal BN and in recipients of a previously successful ITX. Donor specific skin grafts were accepted in the animals that had received DBMC 40 days before the islet allograft, while animals receiving DBMC at the time of the islet allograft rejected the donor specific skin graft similarly to the controls. However, these animals did not reject a second set donor-specific islet transplant. The results indicate that radiation conditioning of the recipients was not necessary to induce microchimerism and graft acceptance in this rodent model of islet allotransplantation.
我们测试了供体骨髓细胞(DBMC)输注对大鼠胰岛同种异体移植存活的影响,且未对受体进行细胞清除预处理。分别使用Lewis大鼠和糖尿病Brown Norway大鼠作为供体和受体。将供体胰岛置于左肾包膜下。输注DBMC并进行短期免疫抑制,随后进行延迟胰岛移植,结果所有胰岛移植物均长期存活(中位生存时间>180天)。对照动物出现反复高血糖(胰岛同种异体移植排斥)。在接受LEW骨髓的BN受体的脾脏和颈部淋巴结中检测到供体骨髓来源的细胞,但仅接受胰岛移植的受体中未检测到。对正常BN大鼠和先前胰岛移植成功的受体进行了第二次全层皮肤移植。在胰岛同种异体移植前40天接受DBMC的动物中,供体特异性皮肤移植被接受,而在胰岛同种异体移植时接受DBMC的动物与对照相似地排斥供体特异性皮肤移植。然而,这些动物并未排斥第二次供体特异性胰岛移植。结果表明,在该啮齿类动物胰岛同种异体移植模型中,诱导微嵌合体和移植物接受并不需要对受体进行辐射预处理。